do you actually know how far behind they are when they said they'll have their first Australian trials... there is no excuse for this and the management has lost a whole lot of trust that's for sure specially for not updating on it alt all... all their other products the market doesn't care about... the only thing that will get this moving is the angelmed and that's the one thing their not updating with shareholders. I can easily say once they get their announcement out about the first ones they'll be a spike in share price and then run back to where we are. dead stock
HYD Price at posting:
17.0¢ Sentiment: Sell Disclosure: Not Held
